ITP Registry and Accompanying Biospecimen Collection
The objective of this ITP registry is to collect clinical information, including biosampling, from consenting patients with a variety of ITPs at different points in the course of their disease.
| Condition(s) | Immune Thrombocytopenia |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The objective of this ITP registry is to collect clinical information, including biosampling, from consenting patients with a variety of ITPs at different points in the course of their disease. |
| Who can participate | Inclusion Criteria: * Primary or secondary Immune Thrombocytopenia (ITP) * Age ≥18 years * signed declaration of consent Exclusion Criteria: * diagnoses that cannot be reconciled with the diagnosis of ITP (esp. heparin-induced thrombocytopenia, pregnancy-associated thrombocytopenia, pseudothrombocytopenia) * no informed consent possible (this covers patients who are unable to understand the nature and scope of participation) |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Jena University Hospital |
| Locations | Aachen, Germany; Altenburg, Germany; Aschaffenburg, Germany; Bad Homburg, Germany; Bad Liebenwerda, Germany; Berlin, Germany (+58 more sites) |
| Start date | 2021-11-29 |
| NCT ID | NCT05152238 |
| Official listing | https://clinicaltrials.gov/study/NCT05152238 |